Billed as nonaddictive, new pain pill could soon win FDA approval
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...
The Washington Post on MSN15d
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
FDA bans red dye No. 3 from food, drinks and ingested drugs in the US
Red dye No. 3 has been permissible for use in food despite the Delaney Clause of the FDA’s Federal Food, Drug, and Cosmetic ...
FDA Approves Weight-loss Drug Zepbound For Sleep Apnea – Will Insurance Cover This $1000-Per-Month Medication?
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
US FDA approves expanded use of Lilly's bowel disease drug
Eli Lilly said on Wednesday the U.S. health regulator has approved its drug to treat adults with moderate-to-severe Crohn's ...
pulmonologyadvisor3d
2024 Novel Drug and Biological Product Approvals
The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.
New York Post21d
FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The the US Food and Drug Administration (FDA) has approved the first medication to ... The agency said that along with the drug, a reduced-calorie diet and increased physical activity should ...
The Washington Post27d
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration on Friday approved ... which help people shave pounds. The FDA first approved Zepbound to treat obesity in November 2023. Its active ingredient, tirzepatide ...